Stay updated on Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial
Sign up to get notified when there's something new on the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page.

Latest updates to the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the study content and indicating that access to the record is blocked.SummaryDifference17%

- Check39 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, reflecting a minor update to the page. This change does not modify study information or how the page operates for users.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a small update to the page's revision history rather than substantive content changes.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a new build. No study details or user-facing content appear to be altered.SummaryDifference0.1%

- Check96 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3.SummaryDifference0.1%

- Check103 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer build or patch of the site. This update does not modify the displayed content.SummaryDifference0.1%

Stay in the know with updates to Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page.